Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Almirall ( (ES:ALM) ) is now available.
Almirall has approved a bonus share capital increase to implement a scrip dividend system, allowing shareholders to choose between receiving their dividend in cash, new shares, or a combination of both. The initiative reflects the company’s use of flexible shareholder remuneration tools that balance cash preservation with equity issuance.
The company has set a detailed timetable running from early May to mid‑June 2026, covering key dates for trading free allotment rights, requesting cash payment, and admitting the new shares to trading on Spanish stock exchanges. Only shareholders holding Almirall stock by 13 May 2026 and recorded in Iberclear on 15 May 2026 will be eligible for the purchase commitment on rights, a structure that may influence trading around the ex‑coupon date and offers existing investors multiple options for realizing value.
The most recent analyst rating on (ES:ALM) stock is a Hold with a EUR14.00 price target. To see the full list of analyst forecasts on Almirall stock, see the ES:ALM Stock Forecast page.
More about Almirall
Almirall, S.A. is a Spanish pharmaceutical company focused on developing and commercializing medicines, particularly in dermatology and related therapeutic areas, with its shares listed on the Spanish stock exchanges and a shareholder base accessing returns through both dividends and equity participation.
Average Trading Volume: 149,849
Technical Sentiment Signal: Buy
Current Market Cap: €2.57B
Learn more about ALM stock on TipRanks’ Stock Analysis page.